Cargando…
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) deve...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775385/ https://www.ncbi.nlm.nih.gov/pubmed/28933003 http://dx.doi.org/10.1007/s40273-017-0572-7 |
_version_ | 1783293895281475584 |
---|---|
author | van Asselt, Thea Ramaekers, Bram Corro Ramos, Isaac Joore, Manuela Al, Maiwenn Lesman-Leegte, Ivonne Postma, Maarten Vemer, Pepijn Feenstra, Talitha |
author_facet | van Asselt, Thea Ramaekers, Bram Corro Ramos, Isaac Joore, Manuela Al, Maiwenn Lesman-Leegte, Ivonne Postma, Maarten Vemer, Pepijn Feenstra, Talitha |
author_sort | van Asselt, Thea |
collection | PubMed |
description | BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) developing a costing tool to support reviewers of grant proposals in assessing whether the proposed budget is realistic. METHODS: For granted study proposals from the Netherlands Organization for Health Research and Development (ZonMw), type of study, potential cost drivers, proposed budget, and general characteristics were extracted. Regression analysis was conducted in an attempt to generate a ‘predicted budget’ for certain combinations of cost drivers, for implementation in the costing tool. RESULTS: Of 133 drug-related research grant proposals, 74 were included for complete data extraction. Because an association between cost drivers and budgets was not confirmed, we could not generate a predicted budget based on regression analysis, but only historic reference budgets given certain study characteristics. The costing tool was designed accordingly, i.e. with given selection criteria the tool returns the range of budgets in comparable studies. This range can be used in VOI analysis to estimate whether the expected net benefit of sampling will be positive to decide upon the net value of future research. CONCLUSION: The absence of association between study characteristics and budgets may indicate inconsistencies in the budgeting or granting process. Nonetheless, the tool generates useful information on historical budgets, and the option to formally relate VOI to budgets. To our knowledge, this is the first attempt at creating such a tool, which can be complemented with new studies being granted, enlarging the underlying database and keeping estimates up to date. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-017-0572-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5775385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-57753852018-01-30 Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research van Asselt, Thea Ramaekers, Bram Corro Ramos, Isaac Joore, Manuela Al, Maiwenn Lesman-Leegte, Ivonne Postma, Maarten Vemer, Pepijn Feenstra, Talitha Pharmacoeconomics Original Research Article BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) developing a costing tool to support reviewers of grant proposals in assessing whether the proposed budget is realistic. METHODS: For granted study proposals from the Netherlands Organization for Health Research and Development (ZonMw), type of study, potential cost drivers, proposed budget, and general characteristics were extracted. Regression analysis was conducted in an attempt to generate a ‘predicted budget’ for certain combinations of cost drivers, for implementation in the costing tool. RESULTS: Of 133 drug-related research grant proposals, 74 were included for complete data extraction. Because an association between cost drivers and budgets was not confirmed, we could not generate a predicted budget based on regression analysis, but only historic reference budgets given certain study characteristics. The costing tool was designed accordingly, i.e. with given selection criteria the tool returns the range of budgets in comparable studies. This range can be used in VOI analysis to estimate whether the expected net benefit of sampling will be positive to decide upon the net value of future research. CONCLUSION: The absence of association between study characteristics and budgets may indicate inconsistencies in the budgeting or granting process. Nonetheless, the tool generates useful information on historical budgets, and the option to formally relate VOI to budgets. To our knowledge, this is the first attempt at creating such a tool, which can be complemented with new studies being granted, enlarging the underlying database and keeping estimates up to date. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-017-0572-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-09-20 2018 /pmc/articles/PMC5775385/ /pubmed/28933003 http://dx.doi.org/10.1007/s40273-017-0572-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Article van Asselt, Thea Ramaekers, Bram Corro Ramos, Isaac Joore, Manuela Al, Maiwenn Lesman-Leegte, Ivonne Postma, Maarten Vemer, Pepijn Feenstra, Talitha Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title | Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title_full | Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title_fullStr | Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title_full_unstemmed | Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title_short | Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research |
title_sort | research costs investigated: a study into the budgets of dutch publicly funded drug-related research |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775385/ https://www.ncbi.nlm.nih.gov/pubmed/28933003 http://dx.doi.org/10.1007/s40273-017-0572-7 |
work_keys_str_mv | AT vanasseltthea researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT ramaekersbram researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT corroramosisaac researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT jooremanuela researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT almaiwenn researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT lesmanleegteivonne researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT postmamaarten researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT vemerpepijn researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch AT feenstratalitha researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch |